Prediction of drug adverse event through gene expression analysis
Not Applicable
- Conditions
- embedded dens molaris
- Registration Number
- JPRN-UMIN000000672
- Lead Sponsor
- JICHI MEDICAL UNIVERSITY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
renal dysfunction (Creatinin equal or greater than 2.0 mg/dl) liver dysfunction (ALT, AST, T-bil, LDH or ALP are more than two times greater than upper limit of normal range) confirmed or clinically suspected myocardial infarction and/or congestive heart failure prescribed medicines for diabetes mellitus and/or hypertension pasthistory for hypersensitivities and/or allargic reactions against Cefcapene Pivoxil Hydrochloride Hydrate or ingredients of Flomox(R) Past history of hypersensitivities for Cephalosporins
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method correlation and differences of gene expression between results from basic experiments in vitro and ones in human
- Secondary Outcome Measures
Name Time Method